Kathryn E Crozier, MD
Neurology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Crozier’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A115111 · Current
Licensed to practise in California · since 2010 · expires 2028-09-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$51,167
Pharmacies billed $51,167 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
537 generic and fewer than 11 brand-name prescriptions · $51,167 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa | 148 | $9,584 | $65 |
| Levetiracetam | 73 | $3,136 | $43 |
| Lacosamide | 17 | $1,792 | $105 |
| Gabapentin | 58 | $1,246 | $21 |
| Oxcarbazepine | 13 | $841 | $65 |
See all 12 drugs
| Carbidopa-Levodopa | 148 | $9,584 | $65 |
| Levetiracetam | 73 | $3,136 | $43 |
| Lacosamide | 17 | $1,792 | $105 |
| Gabapentin | 58 | $1,246 | $21 |
| Oxcarbazepine | 13 | $841 | $65 |
| Lamotrigine | 18 | $753 | $42 |
| Carbidopa-Levodopa Er | 23 | $719 | $31 |
| Primidone | 17 | $700 | $41 |
| Phenytoin Sodium Extended | 11 | $640 | $58 |
| Donepezil | 14 | $238 | $17 |
| Clopidogrel | 11 | $215 | $20 |
| Topiramate | 12 | $198 | $17 |
Year by year
| 2024 | 554 | 166 | None | None | $51,167 |
| 2023 | 512 | 158 | 0% (0) | None | $49,727 |
| 2022 | 438 | 133 | 0% (0) | None | $72,879 |
| 2021 | 450 | 160 | None | None | $69,663 |
| 2020 | 396 | 126 | 0% (0) | None | $54,819 |
| 2019 | 430 | 117 | None | None | $63,156 |
| 2018 | 309 | 101 | 0% (0) | None | $73,176 |
| 2017 | 235 | 69 | 0% (0) | 11% | $87,877 |
| 2016 | 172 | 61 | 0% (0) | 12% | $93,113 |
| 2015 | 168 | 44 | None | 10% | $13,102 |
| 2014 | 30 | None | 0% (0) | 0% | $1,759 |
| 2013 | 46 | 12 | 0% (0) | None | $4,258 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Carbidopa-Levodopa | 133 | $10,462 | $79 |
| Levetiracetam | 73 | $3,064 | $42 |
| Lacosamide | 14 | $1,582 | $113 |
| Phenytoin Sodium Extended | 16 | $912 | $57 |
| Gabapentin | 30 | $822 | $27 |
| Lamotrigine | 18 | $784 | $44 |
| Carbidopa-Levodopa Er | 22 | $775 | $35 |
| Topiramate | 18 | $432 | $24 |
| Atorvastatin | 11 | $321 | $29 |
| Ropinirole | 11 | $275 | $25 |
| Clopidogrel | 11 | $220 | $20 |
2022: 8 drugs
| Glatopa | 15 | $31,466 | $2,098 |
| Carbidopa-Levodopa | 107 | $9,731 | $91 |
| Levetiracetam | 49 | $2,696 | $55 |
| Gabapentin | 38 | $1,235 | $32 |
| Carbidopa-Levodopa Er | 21 | $816 | $39 |
| Phenytoin Sodium Extended | 13 | $657 | $51 |
| Topiramate | 17 | $518 | $30 |
| Lamotrigine | 14 | $386 | $28 |
2021: 8 drugs
| Glatopa | 18 | $27,771 | $1,543 |
| Carbidopa-Levodopa | 125 | $10,848 | $87 |
| Levetiracetam | 55 | $5,214 | $95 |
| Gabapentin | 38 | $1,307 | $34 |
| Phenytoin Sodium Extended | 13 | $715 | $55 |
| Topiramate | 19 | $707 | $37 |
| Lamotrigine | 13 | $658 | $51 |
| Pregabalin | 12 | $432 | $36 |
2020: 6 drugs
| Glatopa | 11 | $16,875 | $1,534 |
| Carbidopa-Levodopa | 126 | $10,425 | $83 |
| Levetiracetam | 48 | $3,696 | $77 |
| Topiramate | 13 | $1,918 | $148 |
| Gabapentin | 28 | $1,243 | $44 |
| Phenytoin Sodium Extended | 12 | $1,050 | $87 |
2019: 6 drugs
| Carbidopa-Levodopa | 141 | $8,406 | $60 |
| Levetiracetam | 44 | $1,845 | $42 |
| Phenytoin Sodium Extended | 19 | $1,636 | $86 |
| Gabapentin | 34 | $1,113 | $33 |
| Topiramate | 12 | $485 | $40 |
| Atorvastatin | 12 | $336 | $28 |
2018: 4 drugs
| Carbidopa-Levodopa | 90 | $5,743 | $64 |
| Levetiracetam | 14 | $1,372 | $98 |
| Atorvastatin | 16 | $555 | $35 |
| Gabapentin | 15 | $526 | $35 |
2017: 8 drugs
| Glatopa | 12 | $44,936 | $3,745 |
| Carbidopa-Levodopa | 59 | $5,048 | $86 |
| Amantadine | 13 | $2,060 | $158 |
| Levetiracetam | 15 | $846 | $56 |
| Gabapentin | 21 | $700 | $33 |
| Carbidopa-Levodopa Er | 12 | $504 | $42 |
| Pramipexole Dihydrochloride | 16 | $257 | $16 |
| Promethazine | 11 | $76 | $7 |
2016: 1 drug
| Carbidopa-Levodopa | 40 | $2,687 | $67 |
2015: 5 drugs
| Gabapentin | 18 | $686 | $38 |
| Carbidopa-Levodopa | 24 | $681 | $28 |
| Propranolol | 11 | $223 | $20 |
| Levetiracetam | 23 | $179 | $8 |
| Donepezil | 11 | $73 | $7 |
Professional record
- NPI
- 1528392610
- Licence
- CA A115111California A115111: Current · expires 2028-09-30
- Trained
- University of California, San Diego School of Medicine, 2009
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Student in a training program (390200000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2009-09-23
- NPI last updated
- 2021-12-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.